New York, New York 10065


Purpose:

The purpose of this study is to identify specific clinical and molecular characteristics that are predictive of tumor progression in small thyroid cancers.


Criteria:

Inclusion Criteria: - Biopsy proven papillary thyroid cancer (or suspicious for papillary thyroid cancer) confirmed by MSKCC cytopathologist. - Being followed with active surveillance at MSKCC - Biopsied index nodule less than or equal to 2 cm in maximum dimension - Thyroid and neck US performed and interpreted by a MSKCC radiologist within 6 months prior to study entry. Exclusion Criteria: - Biopsied index nodule greater than 2 cm in any dimension - Age less than 18 yrs old


NCT ID:

NCT02363595


Primary Contact:

Principal Investigator
Robert Tuttle, MD
Memorial Sloan Kettering Cancer Center

Robert Tuttle, MD
Phone: 646-888-2716


Backup Contact:

Michael Berger, PhD
Phone: 646-888-3386


Location Contact:

New York, New York 10065
United States

Robert Tuttle, MD
Phone: 646-888-2716

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.